More than half of the tumor samples had normal karyotypes; nearly half (6 of 13) bore NPM1 mutation A and most (9 of 13) had FLT3-ITD mutations (Fig 2A), likely reflecting the increased frequency of banked tumor specimens from patients with high white blood cell counts. This evidence concerns the gene NPM1 and neoplasm.